Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria

NCT04629170 is registered in ClinicalTrials.gov with Synlogic as lead sponsor.

NCT NCT04629170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04629170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
Lead sponsor
Synlogic
Phase
Phase 1
Overall status
Completed
Start date
November 4, 2020
Completion date
January 17, 2023
Enrollment
77 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

enteric hyperoxaluria, healthy